2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Familial Primary Pulmonary Hypertension in 1 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Familial Primary Pulmonary Hypertension: Familial or idiopathic hypertension in the PULMONARY CIRCULATION which is not secondary to other disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantoni, S | 1 |
| Galletti, M | 1 |
| Zambelli, F | 1 |
| Valente, S | 1 |
| Ponti, F | 1 |
| Tassinari, R | 1 |
| Pasquinelli, G | 1 |
| Galiè, N | 1 |
| Ventura, C | 1 |
1 other study available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Familial Primary Pulmonary Hypertension
| Article | Year |
|---|---|
Sodium butyrate inhibits platelet-derived growth factor-induced proliferation and migration in pulmonary artery smooth muscle cells through Akt inhibition.
Topics: Acetylation; Animals; Butyric Acid; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Cell | 2013 |